Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualized Neoantigen Vaccine GRANITE for First Line (1L) Maintenance Treatment of Metastatic, Microsatellite-Stable Colorectal Cancer (MSS-CRC)

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability